Literature DB >> 21411988

Renal function improvement with pentavalent antimonial agents in patients with visceral leishmaniasis.

Elizabeth F Daher1, Natália A Rocha, Michelle J C Oliveira, Luiz F L G Franco, Jobson L Oliveira, Geraldo B Silva Junior, Krasnalhia Lívia S Abreu, Guilherme A L Henn, Alice M C Martins, Alexandre B Libório.   

Abstract

BACKGROUND: The aim of this study is to investigate tubular and glomerular function after visceral leishmaniasis (VL) treatment with pentavalent antimonials.
METHODS: This is a prospective study including 14 patients with VL diagnosis treated with pentavalent antimonials. Urine acidification and concentration tests were performed. Estimated glomerular filtration rate (eGFR), fractional excretion of sodium (FE(Na)) and potassium (FE(K)) and free water clearance (C(H2O)) were measured to assess glomerular and tubular function.
RESULTS: The VL group had a significantly lower FE(K), serum sodium and plasma osmolality (P(osm)). No significant differences were found regarding proteinuria, eGFR, FE(Na) or C(H2O). Patients in the VL group had lower urinary osmolality (U(osm)) before DDAVP use when compared to the control group, as well as a lower U/P(osm). The urinary pH before and after CaCl(2) load was higher in the VL group.
CONCLUSION: This study shows evidence of reversal of some tubular dysfunction in VL, but other dysfunctions may persist, especially urinary acidification capacity.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21411988     DOI: 10.1159/000324914

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  4 in total

1.  Renal function evaluation in patients with American cutaneous leishmaniasis after specific treatment with pentavalent antimonial.

Authors:  Rodrigo A Oliveira; Cláudio G Lima; Rosa Ms Mota; Alice Mc Martins; Talita R Sanches; Antônio C Seguro; Lúcia C Andrade; Geraldo B Silva Junior; Alexandre B Libório; Elizabeth F Daher
Journal:  BMC Nephrol       Date:  2012-06-20       Impact factor: 2.388

2.  Visceral leishmaniasis due to Leishmania infantum with renal involvement in HIV-infected patients.

Authors:  Matteo Vassallo; Olivier Moranne; Damien Ambrosetti; Pierre-Yves Jeandel; Christelle Pomares; Elisabeth Cassuto; Annick Boscagli; Guillaume Giraud; Nathalie Montagne; Chiara Dentone; Ilaria Demacina; Barbara Villaggio; Giovanni Secondo; Giuseppe Ferrea; Corinne Passeron; Laurence Saudes; Regis Kaphan; Pierre Marty; Eric Rosenthal
Journal:  BMC Infect Dis       Date:  2014-10-30       Impact factor: 3.090

3.  Continuous hypergammaglobulinemia and proteinuria after the recovery of the visceral Leishmaniasis: a case report.

Authors:  Linfeng Zou; Gang Chen; Yangzhong Zhou; Wei Ye; Yubin Wen; Limeng Chen; Xuemei Li
Journal:  BMC Infect Dis       Date:  2021-01-28       Impact factor: 3.090

Review 4.  Kidney involvement in leishmaniasis--a review.

Authors:  Geraldo Bezerra da Silva Junior; Elvino José Guardão Barros; Elizabeth De Francesco Daher
Journal:  Braz J Infect Dis       Date:  2014-03-29       Impact factor: 3.257

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.